-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IznPGHmlKCujZmHd7xTrpT8bfpDO5P4PQWGlo9maujhmIL1pLAv0Cl35x8iEt5/l j/WJQt5hjfYPdMN4tbIyKg== 0001104659-09-003894.txt : 20090123 0001104659-09-003894.hdr.sgml : 20090123 20090123163019 ACCESSION NUMBER: 0001104659-09-003894 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090121 FILED AS OF DATE: 20090123 DATE AS OF CHANGE: 20090123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Camut Christopher C CENTRAL INDEX KEY: 0001409861 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 09542768 BUSINESS ADDRESS: BUSINESS PHONE: 410-269-2600 MAIL ADDRESS: STREET 1: C/O PHARMATHENE, INC. STREET 2: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMATHENE, INC CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 BUSINESS PHONE: 410 269 2600 MAIL ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 20050505 4 1 a4.xml 4 X0303 4 2009-01-21 1 0001326190 PHARMATHENE, INC PIP 0001409861 Camut Christopher C C/O PHARMATHENE, INC. ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 0 1 0 0 VP, Chief Financial Officer Common Stock, $0.0001 par value per share 2009-01-21 4 A 0 25308 A 49308 D Stock Option (right to buy) 2.46 2009-01-21 4 A 0 25308 A 2019-01-21 Common Stock 25308 240308 D This is a restricted stock award, which vests over a 3 year period with 33 1/3% vesting on the first anniversary of the grant date or 1/21/2010, 33 1/3% vesting on the second anniversary of the grant date or 1/21/2011, and the balance vesting on the third anniversary of the grant date or 1/21/2012. The option vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date. On January 21, 2009, the date such stock options were granted and restricted stock was awarded, the closing price of the Issuer's common stock was $2.46 per share. Exhibit List: Exhibit 24 - Confirming Statement /s/ Roland S. Chase, attorney in fact 2009-01-23 EX-24 2 ex-24.htm EX-24

Exhibit 24

 

CONFIRMING STATEMENT

 

 This Statement confirms that the undersigned has authorized and designated Jordan P. Karp, Christopher C. Camut, Jeffrey A. Baumel and Roland S. Chase (the “Authorized Signatories”), or any one or more of them, to execute and file on the undersigned’s behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned’s ownership of or transactions in securities of PharmAthene, Inc.  The authority of the Authorized Signatories  under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to his/her ownership of, or transactions in, securities of  PharmAthene, Inc., unless earlier revoked in writing.  The undersigned acknowledges that Authorized Signatories are not assuming any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

 

Dated:

  January 22, 2009

 

 

 

Signed:

  /s/ Christopher Camut

 

 

 

Print Name:

  Christopher Camut

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----